4 Green Flags For Jazz Pharmaceuticals’ Buyout of GW Pharmaceuticals
1 minuto de lectura
Pot investors are hardly strangers to splashy mergers and acquisitions. And following the big news about Aphria and Tilray combining their companies, there’s a new deal that’s making waves in the cannabis sector. On Wednesday, Jazz Pharmaceuticals (NASDAQ: JAZZ) announced it’s buRead MoreMarketsMarkets Feed
Descubre más desde Espacioteca
Suscríbete y recibe las últimas entradas en tu correo electrónico.
